Thrombin Activatable Fibrinolysis Inhibitor Deficient Human Plasma is a unique resource for biotechnology and pharmaceutical research. Derived from normal citrated human plasma, this plasma has been depleted of thrombin activatable fibrinolysis inhibitor using selective immunoadsorption using antibodies directed towards thrombin activatable fibrinolysis inhibitor. Creative Biolabs strictly follows standardized processes to collect and process products, ensuring the accuracy and reliability of samples.
Related products